Should microchimerism turn into rejection prophylactics?
- PMID: 20014925
- DOI: 10.1586/erm.09.79
Should microchimerism turn into rejection prophylactics?
Abstract
Non-self cells can circulate in the body of an individual after any sort of contact with an allogeneic source of cells, thus creating a situation of chimerism that can be transient or prolonged over time. This situation may appear after stem cell transplantation, pregnancy, transfusion or transplantation. Concerning transplantation, many hypotheses have been formulated regarding the existence, persistence and role of these circulating cells in the host. We will review the principal hypotheses that have been formulated for years since the first description of non-self circulating cells in mammals to the utilization of artificially induced chimerism protocols for the achievement of tolerance.
Similar articles
-
Mixed chimerism in SCT: conflict or peaceful coexistence?Bone Marrow Transplant. 2008 Sep;42(5):297-310. doi: 10.1038/bmt.2008.212. Epub 2008 Jul 28. Bone Marrow Transplant. 2008. PMID: 18660844 Review.
-
Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA.Br J Haematol. 2009 Mar;144(6):933-45. doi: 10.1111/j.1365-2141.2008.07533.x. Epub 2009 Jan 9. Br J Haematol. 2009. PMID: 19183198
-
[The possible role of microchimerism in the aetiology of autoimmune diseases].Ned Tijdschr Geneeskd. 2005 Jul 9;149(28):1556-60. Ned Tijdschr Geneeskd. 2005. PMID: 16038158 Review. Dutch.
-
Differential dynamics of donor DC and non-DC peripheral blood mononuclear cell microchimerism in lung transplantation.Clin Immunol. 2009 Nov;133(2):179-83. doi: 10.1016/j.clim.2009.07.012. Epub 2009 Aug 19. Clin Immunol. 2009. PMID: 19695959
-
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.
Cited by
-
Five-year clinical effects of donor bone marrow cells infusions in kidney allograft recipients: improved graft function and higher graft survival.Chimerism. 2013 Jul-Sep;4(3):87-94. doi: 10.4161/chim.24719. Epub 2013 May 31. Chimerism. 2013. PMID: 23639966 Free PMC article.
-
Donor-derived peripheral mononuclear cell DNA is associated with stable kidney allograft function: a randomized controlled trial.Chimerism. 2011 Oct-Dec;2(4):102-10. doi: 10.4161/chim.2.4.19095. Chimerism. 2011. PMID: 22509426 Free PMC article. Clinical Trial.
-
Fetal-maternal interface: a chronicle of allogeneic coexistence.Chimerism. 2012 Jan-Mar;3(1):18-20. doi: 10.4161/chim.19439. Chimerism. 2012. PMID: 22690268 Free PMC article.
-
The role and potential of umbilical cord blood in an era of new therapies: a review.Stem Cell Res Ther. 2015 Jul 2;6(1):123. doi: 10.1186/s13287-015-0113-2. Stem Cell Res Ther. 2015. PMID: 26133757 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources